TIS tissue therapies limited

Ann: Regulatory Update , page-12

  1. 1,959 Posts.
    lightbulb Created with Sketch. 186
    As is so often the case, the markets and shareholders have got it wrong. While I became a shareholder for the first time this morning, I am not in this group.

    Lets take a step back for a moment. If the result a few months ago was: "response 210 days, with corresponding CR", would the result have been 44% downturn? Maybe, but I very much doubt it. The smashing this morning is due to the series of events and is being overdone. The negativity around mngt respons. is also weighing on ppls mind. In reality it has nothing to do with them. This is regulatory risk at its finest.

    The astute are going to make some money today.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.